Molecular Carcinogenesis

Papers
(The median citation count of Molecular Carcinogenesis is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
HET0016 attenuates the stemness of breast cancer cells through targeting CYP4Z150
SPI1‐mediated CXCL12 expression in bladder cancer affects the recruitment of tumor‐associated macrophages27
26
25
A novel oncogene trigger transposable element derived‐1 promotes oral squamous cell carcinoma progression via evoking immune inhibition25
RAB6A functions as a critical modulator of the stem‐like subsets in cholangiocarcinoma25
24
Issue Information ‐ Ed Board24
24
Thyroglobulin as a negative marker for malignancy in canine and human breast tumors23
Guangsangon E triggers mitochondria dysfunction and mitophagy in triple‐negative breast cancer and leads to non‐apoptotic cell death22
Hsa_circ_0088036 promotes nonsmall cell lung cancer progression by regulating miR‐1343‐3p/Bcl‐3 axis through TGFβ/Smad3/EMT signaling22
The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5‐fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway20
Cover Image, Volume 61, Issue 720
Issue Information ‐ Ed Board20
19
Issue Information ‐ Ed Board18
HNRNPC promotes estrogen receptor‐positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A‐dependent manner18
Setting up clinical trials for success: Applying preclinical advances in combined TGFβ/PD‐L1 inhibition to ongoing clinical studies18
PLEK2 mediates metastasis and invasion via α5‐nAChR activation in nicotine‐induced lung adenocarcinoma18
ACKR3 orchestrates Hedgehog signaling to promote renal cell carcinoma progression18
ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ‐proteasome pathway17
γ‐Tocotrienol enhances autophagy of gastric cancer cells by the regulation of GSK3β/β‐Catenin pathway17
UBE2D1 promotes glioblastoma proliferation by modulating p21 ubiquitination17
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine17
Latrophilin‐3 as a downstream effector of the androgen receptor induces urothelial tumorigenesis16
Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis15
MCPIP1 expression positively correlates with melanoma‐specific survival of patients, and its overexpression affects vital intracellular pathways of human melanoma cells15
Blast phase of chronic myeloid leukemia with concurrent BCR::ABL1 and SET::NUP214: A report of two cases15
15
The dichotomy of regulatory B cells in cancer versus allergic disease14
Cover Image, Volume 62, Issue 414
IRF2BP2 drives lymphatic metastasis in OSCC cells by elevating mitochondrial fission‐dependent fatty acid oxidation14
14
A rohitukine derivative IIIM‐290 induces p53 dependent mitochondrial apoptosis in acute lymphoblastic leukemia cells14
Synergistic rescue of temperature‐sensitive p53 mutants by hypothermia and arsenic trioxide13
Issue Information ‐ Ed Board13
Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT‐mTOR pathway13
Pyroptosis‐related gene GSDMC indicates poor prognosis and promotes tumor progression by activating the AKT/mTOR pathway in lung squamous cell carcinoma13
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma12
Forkhead Box Q1 is a novel regulator of autophagy in breast cancer cells12
NMI promotes tumor progression and gemcitabine resistance in pancreatic cancer via STAT3‐IFIT3 axis12
GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma12
Valproic acid increased the efficacy of EGFR TKIs on EGFR/TP53 co‐mutated lung cancers and downregulated mutant‐p53 levels12
DUSP22 suppresses tumor progression by directly dephosphorylating AKT in non‐small cell lung cancer12
Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell‐specific molecule 1 expression12
Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells12
Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features12
11
Issue Information ‐ Ed Board11
TMED3 stabilizes SMAD2 by counteracting NEDD4‐mediated ubiquitination to promote ovarian cancer10
Regulation of SELENOF translation by eIF4a3: Possible role in prostate cancer progression10
Potentially functional genetic variants in interferon regulatory factor family genes are associated with colorectal cancer survival10
EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway10
Insulin‐like growth factor (IGF) and hepatocyte growth factor (HGF) in follicular fluid cooperatively promote the oncogenesis of high‐grade serous carcinoma from fallopian tube epithelial cells: Disse10
10
Systematical identification of key genes and regulatory genetic variants associated with prognosis of esophageal squamous cell carcinoma10
CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas10
The Parkinson's disease‐associated protein α‐synuclein inhibits hepatoma by exosome delivery10
Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carc9
Withaferin A mediated changes of miRNA expression in breast cancer‐derived mammospheres9
Monocarboxylate transporter 1 is a novel target for breast cancer stem like‐cell inhibition by diallyl trisulfide9
MiR‐15a‐3p regulates ferroptosis via targeting glutathione peroxidase GPX4 in colorectal cancer9
Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance‐mediated oxaliplatin chemoresistance in colorectal cancer9
Hyperactivation of MEK/ERK pathway by Ca2+/calmodulin‐dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin‐dependent kinases and minichromosome maintenance9
Nutlin‐3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation9
The Effect of Gender on the Intestinal Flora of Colorectal Cancer Under Different Stages9
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway9
HIF‐1α‐regulated stanniocalcin‐1 mediates gemcitabine resistance in pancreatic ductal adenocarcinoma via PI3K/AKT signaling pathway9
HPV‐16/18 E6‐induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D19
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway9
SIRT1 promotes doxorubicin‐induced breast cancer drug resistance and tumor angiogenesis via regulating GSH‐mediated redox homeostasis8
USP9X deubiquitinates and stabilizes CDC123 to promote breast carcinogenesis through regulating cell cycle8
Urinary parabens and breast cancer risk: Modification by LINE‐1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status8
PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt/β‐catenin pathway8
PTPN2 Expression in Hypopharyngeal Squamous Cell Carcinoma and Its Clinical Significance8
RELA promotes the progression of oral squamous cell carcinoma via TFAP2A‐Wnt/β‐catenin signaling8
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney rena8
FOXM1‐Cx31 Axis Drives Pancreatic Cancer Stem Cell‐Like Properties and Chemoresistance8
Phosphoproteomics of extracellular vesicles integrated with multiomics analysis reveals novel kinase networks for lung cancer7
Alkaliptosis induction counteracts paclitaxel‐resistant ovarian cancer cells via ATP6V0D1‐mediated ABCB1 inhibition7
Wogonin Inhibits Ovarian Cancer by Activating the AMPK‐TET2‐5hmC Axis7
CircTCF25 serves as a sponge for miR‐206 to support proliferation, migration, and invasion of glioma via the Jak2/p‐Stat3/CypB axis7
Methylation, Gene Expression, and Risk Genotypes at the TERTCLPTM1L Locus in Cervical Cancer7
Characterizing Genetic Susceptibility to Colorectal Cancer in Taiwan Through Genome‐Wide Association Study7
Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo7
Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer7
Delta‐Like Homolog 2 Facilitates Malignancy of Hepatocellular Carcinoma via Activating EGFR/PKM2 Signaling Pathway7
ZNF480 Accelerates Chemotherapy Resistance in Breast Cancer by Competing With TRIM28 and Stabilizing LSD1 to Upregulate the AKT‐GSK3β‐Snail Pathway7
Integrating Multi‐Omics Data to Uncover Prostate Tissue DNA Methylation Biomarkers and Target Genes for Prostate Cancer Risk7
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway through RAB27B7
Venetoclax overcomes resistance to all‐trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion7
Sohlh2 Promotes the Progression of Hepatocellular Carcinoma via TGM2‐Mediated Autophagy7
microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX27
7
Mass cytometry and transcriptomic profiling reveal PD1 blockade induced alterations in oral carcinogenesis6
Common tumor‐suppressive signaling of thyroid hormone receptor beta in breast and thyroid cancer cells6
RETRACTION: “LncAPC Drives Wnt/Β‐Catenin Activation and Liver TIC Self‐Renewal Through EZH2 Mediated APC Transcriptional Inhibition”6
Predictive Value of Neutrophil Extracellular Traps in Neoadjuvant Chemotherapy for Muscle‐Invasive Bladder Cancer6
Identification of ATAD3A as a key regulator in non‐small cell lung cancer by promoting STAT3‐induced cell proliferation and tumor angiogenesis6
Translational relevance of SOS1 targeting for KRAS‐mutant colorectal cancer6
6
Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case6
Molecular subtypes identified by multiomics analysis based on cuproptosis‑related genes precisely predict response to immunotherapy and chemotherapy in colorectal cancer6
Intratumoural heterogeneity and clone evolution of oral squamous cell carcinoma6
RETRACTED: LINC02381 aggravates breast cancer through the miR‐1271‐5p/FN1 axis to activate PI3K/AKT pathway6
6
CD137 Protein Expression Pattern Determines the Functional Role of Galectin‐9 in Colorectal Cancer6
A potential signaling axis between RON kinase receptor and hypoxia‐inducible factor‐1 alpha in pancreatic cancer6
Cip2a induces arginine biosynthesis and promotes tumor progression in non‐small cell lung cancer6
6
Molecular and immune targets in cutaneous squamous cell carcinoma6
Corrigendum6
DSN1 Interaction With Centromere‐Associated Proteins Promotes Chromosomal Instability in Hepatocellular Carcinoma6
The Mechanism of TRIM21 Inhibiting the Invasion and Migration of ccRCC by Stabilizing ASS16
Circ_0007429/miR‐637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC6
Cover Image, Volume 61, Issue 26
A novel high‐risk model identified by epithelial–mesenchymal transition predicts prognosis and radioresistance in rectal cancer5
Role of RNA modifications in carcinogenesis and carcinogen damage response5
Role of solute carrier transporters SLC25A17 and SLC27A6 in acquired resistance to enzalutamide in castration‐resistant prostate cancer5
Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma5
Issue Information ‐ Ed Board5
A two‐stage genome‐wide association study identified four potential early‐onset nonsmall cell lung cancer risk loci based on 26,652 participants in Chinese population5
Enrichment of progenitor cells by 2‐acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo5
Issue Information ‐ Ed Board5
Downregulation of C1R promotes hepatocellular carcinoma development by activating HIF‐1α‐regulated glycolysis5
ITGB3‐enriched extracellular vesicles mediate the formation of osteoclastic pre‐metastatic niche to promote lung adenocarcinoma bone metastasis5
5
Cover Image, Volume 63, Issue 55
Saponin from Platycodi radix inactivates PI3K/AKT signaling pathway to hinder colorectal cancer cell proliferation, invasion, and migration through miR‐181c/d‐5p/RBM475
lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer5
Issue Information ‐ Ed Board5
SYT7 as a Potential Prognostic Marker Promotes the Metastasis of Epithelial Ovarian Cancer Cells by Activating the STAT3 Pathway5
14‐3‐3σ/Stratifin and p21 limit AKT‐related malignant progression in skin carcinogenesis following MDM2‐associated p53 loss5
Conditional deletion of mTOR discloses its essential role in early B‐cell development5
Glutaminase potentiates the glycolysis in esophageal squamous cell carcinoma by interacting with PDK15
The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype5
A novel hypoxia‐stimulated lncRNA HIF1A‐AS3 binds with YBX1 to promote ovarian cancer tumorigenesis by suppressing p21 and AJAP1 transcription5
4
Issue Information ‐ Ed Board4
4
Autophagy modulates FSS‐induced epithelial–mesenchymal transition in hepatocellular carcinoma cells4
Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway4
miR‐506‐loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple‐negative breast cancer aggressiveness4
Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype4
DNTT activation, TdT‐aided gene length mutation, and better prognosis in ATG‐based regimen allo‐HSCT in AML4
Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer4
Issue Information ‐ Ed Board4
Issue Information ‐ Ed Board4
Long noncoding RNA TFAP2A‐AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression4
4
Issue Information ‐ Ed Board4
Tumor‐derived extracellular vesicles confer 5‐fluorouracil resistance in esophageal cancer via long noncoding RNA AC116025.2 delivery4
Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV‐related hepatocellular carcinoma survival4
SCR7, an inhibitor of NHEJ can sensitize tumor cells to ionization radiation4
Atypical BCR‐ABL1 transcript in mixed phenotype acute leukemia with bone marrow necrosis4
Issue Information ‐ Ed Board4
4
Plasma cell‐free DNA methylome profiling in pre‐ and post‐surgery oral cavity squamous cell carcinoma4
Issue Information ‐ Ed Board4
In vivo CRISPR–Cas9 knockout screening using quantitative PCR identifies thymosin beta‐4 X‐linked that promotes diffuse‐type gastric cancer metastasis4
4
Novel MLL/KMT2A‐MON2 fusion in a child with therapy‐related acute myeloid leukemia after treatment for acute promyelocytic leukemia4
4
YTHDF1 enhances stemness and chemoresistance in triple‐negative breast cancer cells by upregulating SIAH24
Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP‐J/NRF2/FDX1 pathway4
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism4
Issue Information ‐ Ed Board4
VPS45 Contributes to the Progression of Hepatocellular Carcinoma by Triggering the Wnt/β‐Catenin Signaling Pathway4
Transmembrane protein 147, as a potential Sorafenib target, could expedite cell cycle process and confer adverse prognosis in hepatocellular carcinoma4
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway4
Issue Information ‐ Ed Board4
FOS‐Mediated PLCB1 Induces Radioresistance and Weakens the Antitumor Effects of CD8+ T Cells in Triple‐Negative Breast Cancer3
PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia3
Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk3
Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients3
Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor‐positive breast cancer3
Alternative splicing: An important regulatory mechanism in colorectal carcinoma3
Homologous recombination repair gene mutations in colorectal cancer favors treatment of immune checkpoint inhibitors3
PKMYT1 induced by YAP/TEAD1 gives rise to the progression and worse prognosis of bladder cancer3
NUAK family kinase 2 is a novel therapeutic target for prostate cancer3
Loss of SETD2‐mediated downregulation of intracellular and exosomal miRNA‐10b determines MAPK pathway activation and multidrug resistance in renal cancer3
Targeting mitochondrial metabolism for metastatic cancer therapy3
ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β‐catenin pathway3
CNOT4 suppresses nonsmall cell lung cancer progression by promoting the degradation of PAF13
Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan3
Oncogenic fusion of CD63‐BCAR4 contributes cancer stem cell‐like properties via ALDH1 activity3
FOXD3 suppresses epithelial–mesenchymal transition through direct transcriptional promotion of SMAD7 in esophageal squamous cell carcinoma3
The relationship of nutritional status with anticancer immunity and its prognostic value for head and neck cancer3
VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype3
Issue Information ‐ Ed Board3
Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF‐1α/ATG5 axis3
AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway3
KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer3
Colorectal cancer risk susceptibility loci in a Swedish population3
Eugenol modulates genomic methylation and inactivates breast cancer‐associated fibroblasts through E2F1‐dependent downregulation of DNMT1/DNMT3A3
Blocking the ATR‐SerRS‐VEGFA pathway targets angiogenesis for UV‐induced cutaneous squamous cell carcinoma3
Crucial role of glucosylceramide synthase in the regulation of stem cell‐like cancer cells in B16F10 murine melanoma3
Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model3
p110CUX1 promotes acute myeloid leukemia progression via regulating pyridoxal phosphatase expression and activating PI3K/AKT/mTOR signaling pathway3
Ubiquitin ligase MARCH8 promotes the malignant progression of hepatocellular carcinoma through PTEN ubiquitination and degradation3
Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity3
Issue Information ‐ Ed Board3
An integrative analysis reveals the prognostic value and potential functions of PSMD11 in hepatocellular carcinoma3
Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells3
Transcriptional activation of S100A2 expression by HIF‐1α via binding to the hypomethylated hypoxia response elements in HCC cells3
C5AR1‐induced TLR1/2 pathway activation drives proliferation and metastasis in anaplastic thyroid cancer3
Tumor‐derived exosomes: Key players in non‐small cell lung cancer metastasis and their implication for targeted therapy3
Alternative splicing‐related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR‐199a‐5p/SRSF1 axis and impacting Anillin3
SN‐38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2‐related factor 2 and enhances drug sensitivity of colorectal cancer cells3
Energy Metabolic Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Preliminary Landscape of Warburg Effect in Oral Cancer3
Revisiting laminin and extracellular matrix remodeling in metastatic squamous cell carcinoma: What have we learned after more than four decades of research?2
Issue Information ‐ Ed Board2
2
Therapeutic potential of the novel Bcl‐2/Bcl‐XL dual inhibitor, APG1252, alone or in combination against non‐small cell lung cancer2
2
The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells2
Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells2
Issue Information ‐ Ed Board2
Corrigendum2
2
Issue Information ‐ Ed Board2
LATS‐regulated nuclear‐cytoplasmic translocation of SREBP2 inhibits hepatocellular carcinoma cell migration and invasion via epithelial–mesenchymal transition2
Issue Information ‐ Ed Board2
Withaferin A inhibits breast cancer‐induced osteoclast differentiation2
LINC00355 promotes gastric carcinogenesis by scaffolding p300 to activate CDC42 transcription and enhancing HNRNPA2B1 to stabilize CDC42 mRNA dependent on m6A2
Cover Image, Volume 60, Issue 112
Role of hemoglobin alpha and hemoglobin beta in non‐small‐cell lung cancer based on bioinformatics analysis2
FTO promotes the progression of retinoblastoma through YTHDF2‐dependent N6‐methyladenosine modification in E2F32
Issue Information ‐ Ed Board2
Twist1 as a target for prevention of cutaneous squamous cell carcinoma2
Expression of Concern: Amplification of Cyclinl1 in Uterine Cervical Carcinoma Has Prognostic Implications2
Oscillatory hypoxia induced gene expression predicts low survival in human breast cancer patients2
Circ‐E‐Cad encodes a protein that promotes the proliferation and migration of gastric cancer via the TGF‐β/Smad/C‐E‐Cad/PI3K/AKT pathway2
PARP5B is required for nonhomologous end joining during tumorigenesis in vivo2
Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells2
2
Stage‐specific differential expression of zinc transporter SLC30A and SLC39A family proteins during prostate tumorigenesis2
Issue Information ‐ Ed Board2
ABHD6 suppresses colorectal cancer progression via AKT signaling pathway2
Cover Image, Volume 61, Issue 82
Issue Information ‐ Ed Board2
Cover Image, Volume 62, Issue 92
Divergence of mutational signatures in association with breast cancer subtype2
Corrigendum2
Lentiviral vector transduction provides nonspecific immunogenicity for syngeneic tumor models2
Insulin‐like growth factor‐2 mRNA‐binding protein 3 promotes cell migration, invasion, and epithelial−mesenchymal transition of esophageal squamous cell carcinoma cells by targeting zinc finger E‐box‐2
Mitochondria‐targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species2
KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis2
Circ_0001589/miR‐1248/HMGB1 axis enhances EMT‐mediated metastasis and cisplatin resistance in cervical cancer2
0.11339092254639